ClinicalTrials.Veeva

Menu

Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System

Colgate-Palmolive logo

Colgate-Palmolive

Status and phase

Completed
Phase 3

Conditions

Health Adult Subjects

Treatments

Device: Gingival Barrier
Device: Soft Manual Toothbrush
Drug: Fluoride Toothpaste
Combination Product: Opalescence Boost PF
Combination Product: Philips Zoom Professional Whitening Treatment
Drug: Beaming White
Device: CP LED

Study type

Interventional

Funder types

Industry

Identifiers

NCT07225478
CRO-2025-09-WHT-MS

Details and patient eligibility

About

The goal of this clinical study is to evaluate how well a new in-office whitening system works to whiten teeth compared to some other commercially available in-office whitening systems.

Enrollment

180 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Signed Informed Consent Form
  • Male and female subjects aged 18-70 years, inclusive;
  • Good general health and good oral health based on the opinion of the study investigator;
  • All maxillary natural anterior teeth (teeth #6 through #11) must be present;
  • Availability for the duration of the study;
  • Minimum average Vita Extended Bleachedguide 3D-Master shade score of 17 ≥ or darker.

Exclusion criteria

  • Presence of orthodontic appliances and/or any anterior tooth with a prosthetic crown, veneer, or deemed non-vital;
  • Obvious signs of periodontal disease, rampant caries, or any condition that the dental examiner considers exclusionary from the study.
  • Five or more carious lesions requiring immediate care.
  • Concurrent participation in another oral clinical study.
  • Self-reported pregnant and/or lactating women.
  • History of allergies or sensitivity to tooth whitening products, hydrogen peroxide, personal care consumer products, or their ingredients;
  • Restorations on the teeth to be scored which may interfere with scoring procedures.
  • Have used professional whitening products within one (1) year and/or had dental prophylaxis (professional dental cleaning) within thirty (30) days prior to the start of the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

180 participants in 3 patient groups

NextGen In-Office Whitening System
Experimental group
Description:
Providers will apply NextGen in-office whitening according to detailed instructions included in Appendix XII of the protocol. This includes application of a gingival barrier, followed by application of the whitening gel to the teeth directly for 3 sessions of 15 minutes each. An LED tray will also be worn during these sessions. Afterwards, all gel, barriers and isolation will be removed. Participants will be given a toothbrush and toothbrush for home use, and instructed to brush for 2 minutes twice a day.
Treatment:
Device: CP LED
Drug: Beaming White
Drug: Fluoride Toothpaste
Device: Soft Manual Toothbrush
Device: Gingival Barrier
Zoom In-Office Whitening System
Active Comparator group
Description:
Providers will apply Zoom in-office whitening according to the manufacturer's instructions, included in Appendix XII of the protocol. This includes application of a gingival barrier, followed by application of the whitening gel to the teeth directly for 3 sessions of 15 minutes each, and use of the Philips Zoom Whitespeed Lamp. Afterwards, all gel, barriers and isolation will be removed. Participants will be given a toothbrush and toothbrush for home use, and instructed to brush for 2 minutes twice a day.
Treatment:
Combination Product: Philips Zoom Professional Whitening Treatment
Drug: Fluoride Toothpaste
Device: Soft Manual Toothbrush
Opalescence In-Office Whitening System
Active Comparator group
Description:
Providers will apply Opalescence in-office whitening according to the manufacturer's instructions, included in Appendix XII of the protocol. This includes application of a gingival barrier, followed by application of the whitening gel to the teeth directly for 3 sessions of 20 minutes each. Afterwards, all gel, barriers and isolation will be removed. Participants will be given a toothbrush and toothbrush for home use, and instructed to brush for 2 minutes twice a day.
Treatment:
Combination Product: Opalescence Boost PF
Drug: Fluoride Toothpaste
Device: Soft Manual Toothbrush

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems